N-acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis

Medical Mycology

Volumn 50, Issue 3, 2012, Pages 252-258

  Ishijima, Sanae A ^a   Hayama, Kazumi ^a   Takahashi, Miki ^a   Holmes, Ann R ^b   Cannon, Richard D ^b   Abe, Shigeru ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Mucosal infection; Murine model; N acetylglucosamine; Oral candidiasis; Osteoarthritis nutritional therapy

Indexed keywords

GLUCOSE; METHYLCELLULOSE; N ACETYLGLUCOSAMINE; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PATHOGEN LOAD; THRUSH;

ACETYLGLUCOSAMINE; ADMINISTRATION, ORAL; ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; FOOD; HISTOCYTOCHEMISTRY; HUMANS; HYPHAE; MICE; MICE, INBRED ICR; MICROSCOPY; TONGUE; VIRULENCE;

CANDIDA ALBICANS; MURINAE; MUS;

EID: 84858381342     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.598194     Document Type: Article

References (21)

1. Schelenz S, Abdallah S, Gray G, et al. Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors. J Oral Pathol Med 2011; 40: 83-89.
2. Seneviratne CJ, Jin L, Samaranayake LP. Biofilm lifestyle of Candida: a mini review. Oral Diseases 2008; 14: 582-590.
3. Ellepola ANB, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000; 11: 172-198. (Pubitemid 30481379)
4. Thompson GR III, Patel PK, Kirkpatrick WR, et al. Oropharyngeal candidiasis in the era of antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 488-495.
5. Kumamoto CA, Vinces MD. Contributions of hyphae and hypha-co-regulated genes to Candida albicans virulence. Cell Microbiol 2005; 7: 1546-1554. (Pubitemid 41511912)
6. Simonetti N, Strippoli N, Cassone A. Yeast-mycelial conversion induced by N-acetyl-D-glucosamine in Candida albicans. Nature 1974; 250: 344-346.
7. Shepherd MG, Chiew YY, Ram SP, et al. Germ-tube induction in Candida albicans. Can J Microbiol 1980; 26: 21-26.
8. Huang G, Yi S, Sahni N, et al. N-acetyl glucosamine induces white to opaque switching, a mating prerequisite in Candida albicans. PLoS Pathogens 2010; 6: 1-13.
9. Lohse MB, Johnson AD. White-opaque switching in Candida albi-cans. Curr Opin Microbiol 2009; 12: 650-654.
10. Chen JK, Shen CR, Liu CL. N-acetylglucosamine: production and applications. Mar Drugs 2010; 8: 2493-2516.
11. Usha PR, Naidu MUR. Randomized, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Invest 2004; 24: 353-363. (Pubitemid 38858258)
12. Lee YH, Woo JH, Choi SJ, et al. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int 2010; 30: 357-363.
13. Marr KA, Lyons CN, Kien HA, et al. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Anti-microb Agents Chemother 2001; 45: 52-59. (Pubitemid 32039093)
14. Kamagata-Kiyoura Y, Abe S. Recent studies on oral candidiasis using a murine model. J Oral Biosci 2005; 47: 60-64.
15. Takakura N, Sato Y, Ishibashi H, et al. A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Micro-biol Immunol 2003; 47: 321-326. (Pubitemid 36604617)
16. Kamagata-Kiyoura Y, Abe S, Yamaguchi H, et al. Detachment activity of human saliva in vitro for Candida albicans cells attached to a plastic plate. J Infect Chemother 2003; 9: 215-220. (Pubitemid 37288284)
17. Abe S, Satoh T, Tokuda Y, et al. A rapid colorimetric assay for determination of leukocyte-mediated inhibition of mycelial growth of Candida albicans. Microbiol Immunol 1994; 38: 385-388.
18. Sohanpal BK, EI-Labany S, Lahooti M, et al. Integrated regulatory responses of fmB to N-acetylneuraminic (sialic) acid and GlcNAc in Es-cherichia coli K12. Proc Natl Acad Sci USA 2004; 101: 16322-16327. (Pubitemid 39552843)
19. Singh P, Ghosh S, Datta A. Attenuation of virulence and changes in morphology in Candida albicans by disruption of the N-Acetyl glu-cosamine catabolic pathway. Infect Immun 2001; 69: 7898-7903. (Pubitemid 33086623)
20. Homer KA, Patel R, Beighton D. Effects of N-acetylglucosamine on carbohydrate fermentation by Streptococcus mutans NCTC 10449 and Streptococcus sobrinus SL-1. Infect Immun 1993; 61: 295-302. (Pubitemid 23015430)
21. Lev-Sagie A, Nyirjesy P, Tarangelo N, et al. Hyaluronan in vaginal secretions: association with vulvovaginal candidiasis. Am J Obstet Gynecol 2009; 201: 206.e1-5.